(Binswanger’s Disease; Senile Dementia; Binswanger’s Type; Vascular Cognitive Impairment; Arteriosclerotic Dementia; Atherosclerotic Disease)
by Cynthia M. Johnson, MA
Vascular dementia (VD) is a type of dementia. It is caused by disease of the small blood vessels in the brain. This makes it harder for your brain to get the oxygen it needs to work.
VD occurs when brain cells die because they do not get enough oxygen and nutrients. This is due to hardening and narrowing of the blood vessels in the brain.
VD is more common in older adults.
Having one or more of these risk factors may raise your chance of VD:
In some people, signs of VD appear quickly with changes like those caused by a stroke. Sometimes, the small strokes that lead to VD can happen without other signs. This makes VD hard to detect.
In some cases, things may stay the same or even get better. But VD worsens in most people.
The main symptoms of VD are:
Other symptoms are:
VD can look like other causes of dementia, such as Alzheimer.
Your doctor will ask about your symptoms and health history. A physical exam will be done.
Your bodily fluids may be tested. This can be done with blood tests.
Pictures may be taken of your brain and body structures. This can be done with:
Cognitive testing may also be done.
There is no known cure for VD. The goal is to slow VD and make your quality of life better.
You may be given medicine control mental health problems, such as depression and confusion.
You may also be given medicine to treat other conditions you may have, such as:
Taking these steps may reduce your risk of VD:
National Institute of Neurological Disorders and Stroke
Alzheimer Society of Canada
Heart & Stroke Foundation
Caplan LR. Binswanger’s disease—revisited. Neurology. 1995;45(4):626-633.
Kirschner H. Vascular dementia: a review of recent evidence for prevention and treatment. Curr Neurol Neurosci Rep. 2009;9(6):437-442.
Purkayastha S, Fadar O, Mehregan A, et al. Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage. J Cereb Blood Flow Metab. 2014;34(2):228-234.
Roman GC. Brain hypoperfusion: a critical factor in vascular dementia. Neurol Res. 2004;26(5):454-458.
Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1(7):426-436.
Sabayan B, Sorond FA. Reducing risk of dementia in older age. JAMA. 2017;317(19):2028.
Smith EE. Leukoariosis and stroke. Stroke. 2010;41(10 Suppl):S139-S143.
Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens. 2008;30(8):744-766.
Vascular cognitive impairment. EBSCO DynaMed Plus website. Available at: http://www.dynamed... . Updated November 8, 2017. Accessed June 14, 2018.
Vascular dementia. Alzheimer's Association website. Available at:
...(Click grey area to select URL)
Accessed June 14, 2018.
Vascular dementia: A resource list. National Institute on Aging website. Available at: https://www.nia.nih.gov/health/vascular-dementia-and-vascular-cognitive-impairment-resource-list. Accessed June 14, 2018.
9/3/2014 DynaMed's Systematic Literature Surveillance. Available at: http://www.dynamed...: Wippold FJ, Brown DC, Broderick DF, et al. American College of Radiology (ACR) Appropriateness Criteria for dementia and movement disorders. Available at:
...(Click grey area to select URL)
Updated 2014. Accessed September 3, 2014.
Last reviewed May 2018 by EBSCO Medical Review Board Rimas Lukas, MD
Last Updated: 6/14/2018
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.